Actelion To Acquire Trophos
Trophos’ compound Olesoxime has completed the recruitment of patients into a Phase III study in amyotrophic lateral sclerosis (ALS), an orphan disease also known as Lou Gehrig’s disease.
Faeth Therapeutics has received the US Food and Drug Administration’s (FDA) fast track designation for the sapanisertib and serabelisib (PIKTOR) with paclitaxel combination to treat advanced or recurrent endometrial cancer.
Bioline manufactures and distributes specialised molecular biology reagents for the life science research, biotech, pharmaceutical, and commercial diagnostic markets in Germany, Australia, and the US. Meridian said that,